Anti‐factor IXa/X bispecific antibody (ACE910): hemostatic potency against ongoing bleeds in a hemophilia A model and the possibility of routine supplementation

Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

Marilyn J. Manco‐Johnson, Thomas C. Abshire, Amy D. Shapiro et al. · New England Journal of Medicine · 2007 · 1.9K citations · Full text

Medicine, Hematology, Orthopedic Surgery +13

Guidelines for the management of hemophilia

Alok Srivastava, A. Brewer, Evelien P. Mauser‐Bunschoten et al. · Haemophilia · 2012 · 1.9K citations · Full text

Medicine, Hematology, Internal Medicine +16

A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model

Takehisa Kitazawa, Tomoyuki Igawa, Zenjiro Sampei et al. · Nature Medicine · 2012 · 496 citations

Medicine, Hematology, Immunology +17

A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study

Jan Astermark, Sharyne Donfield, Donna DiMichele et al. · Blood · 2006 · 471 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

The principal results of the International Immune Tolerance Study: a randomized dose comparison

C. R. M. Hay, Donna DiMichele · Blood · 2011 · 440 citations · Full text

Life Sciences, Immunology, Pharmacology +5